A metabolic clock from 18,000 blood samples

Science Translational Medicine via Brightsurf · Article

Researchers profiled plasma metabolites from 18,476 people aged 1 to 96 at six clinical centres in China, and built aging-clock models from the 56 metabolites that shift most reliably with age. Their headline metric, metabolomic age acceleration, tracked higher risk of fatty liver disease, hypertension, diabetes and death from any cause; a second metric rose with the severity of systemic disease.

Key takeaways:

• Metabolites sit downstream of genes, diet and organ function, so a metabolic clock reads current physiological state rather than fixed inheritance - closer to a dashboard than a birth certificate
• The approach runs on blood chemistry, which fits existing laboratory infrastructure better than DNA-methylation arrays - the practical barrier that has limited epigenetic clocks
• The cohort is Chinese only: metabolite levels vary with ancestry, diet and environment, so the clock needs validation in other populations before wider use

Hype check: Proven - an association between metabolic age acceleration and disease and mortality risk in one very large cohort. Promising - clinical risk monitoring, pending prospective and cross-population validation. Marketing - any claim that lowering your metabolic age extends life; no intervention was tested.